Hematopoietic stem cells (HSCs) are dormant in the bone marrow and can be activated in response to diverse stresses to replenish all blood cell types. We identified the ubiquitin ligase Huwe1 as a crucial regulator of HSC function via its posttranslational control of the oncoprotein N-myc (encoded by Mycn). We found Huwe1 to be essential for HSC self-renewal, quiescence and lymphoid-fate specification in mice. Through the use of a fluorescent fusion allele (Mycn M ), we observed that N-myc expression was restricted to the most immature, multipotent stem and progenitor populations. N-myc expression was upregulated in response to stress or following loss of Huwe1, which led to increased proliferation and stem-cell exhaustion. Mycn depletion reversed most of these phenotypes in vivo, which suggested that the attenuation of N-myc by Huwe1 is essential for reestablishing homeostasis following stress.
HSCs have the unique ability to self-renew and differentiate into all mature blood lineages. Although HSCs are a predominantly quiescent population, they can respond dynamically to extrinsic cues such as injury and infection 1 . HSC exhaustion is the phenomenon whereby this typically quiescent population is driven to proliferate abnormally and the balance between asymmetric, self-renewing divisions is skewed toward rapid symmetric divisions, eventually leading to a premature depletion of the stem cell pool 2 . Chronic inflammation, inhibition of cyclin-dependent kinase inhibitors or loss of particular angiocrine factors in the bone marrow niche can all lead to stem cell exhaustion 3 . Thus, to prevent stem-cell exhaustion, mechanisms must exist in HSCs to attenuate proliferative signals.
The transition from the resting (G 0 ) cell state to the activated (G 1 ) cell state is driven mainly by the accumulation of biomass, manifested by increased transcriptional and translational activity, along with greater uptake and anabolism of biosynthetic precursors 4 . The Myc family of proto-oncoproteins (c-Myc (encoded by Myc), N-myc (encoded by Mycn) and L-myc (encoded by Mycl)) are particularly relevant in this context, as these have been shown to influence transcription of a wide range of genes encoding products required for cell growth and DNA replication 5, 6 . Myc mRNA and Mycn mRNA are expressed at roughly equivalent levels in HSCs 7 . Conditional deletion of Myc has been shown to inhibit the differentiation of HSCs, whereas deletion of both Myc and Mycn leads to rapid depletion of the stem-cell pool 7, 8 . As proteins, c-Myc and N-myc exhibit extensive post-translational modifications and are notably unstable [9] [10] [11] . The turnover of Myc proteins is determined by a cascade of phosphorylation and ubiquitination events, which target them for ubiquitinmediated proteolysis 12, 13 .
The ubiquitin ligase SCF Fbxw7 has been shown to be a critical regulator of HSC quiescence [14] [15] [16] , and the stem-cell exhaustion observed in mice with conditional knockout of Fbxw7 (which encodes its substrate-binding component) is dependent on the abundance of c-Myc protein 14 . The ubiquitin ligase Huwe1 (also called Mule or ARF-BP1) has been shown to ubiquitinate many of the same substrates as Fbxw7 does, including Mcl1, c-Myc and N-myc [17] [18] [19] . Furthermore, Huwe1 is suggested to be a determinant of neural stemcell self-renewal and differentiation 20 . Thus, we hypothesized that the two ligases might act in a similar or concerted fashion in HSCs.
We found that conditional knockout of Huwe1 in the hematopoietic system led to a loss of HSC self-renewal and impaired lymphoid specification at the earliest stages of differentiation. Through the use of knock-in alleles encoding fluorescent fusion proteins, we observed at the single-cell level that loss of Huwe1 led to stabilization of its substrate N-myc. Attenuation of N-myc by Huwe1 was essential for maintaining the quiescence of adult HSCs, as we found that depletion of Mycn in Huwe1-deficient HSCs led to restoration of the stem cell pool. Our results further illustrate the complex regulation of Myc transcription factors by the ubiquitin proteasome system in immunesystem development.
RESULTS
Huwe1 is essential for HSC maintenance and recovery from stress Analysis of RNA-sequencing data from sorted populations of hematopoietic cells revealed that the gene encoding Huwe1 ('HECT, UBA and WWE-domain-containing 1, E3 ubiquitin protein ligase') was among the genes with the highest expression encoding products related to ubiquitin conjugation in HSCs 21 (Supplementary Fig. 1a ). Huwe1 expression decreased during early stages of differentiation, but Huwe1 had abundant expression in mature lymphoid populations (B cells, T cells and NK cells) ( Supplementary Fig. 1b) . To investigate whether Huwe1 has a role in hematopoiesis, we used mice with a loxP-flanked Huwe1 allele and Cre recombinase expressed transgenically via the promoter of the polyinosinic:polycytidylic acid (pI:pC)-inducible gene Mx1 (Huwe1 F/Y Mx1-Cre + ) to induce deletion of Huwe1 in HSCs (and their progeny) in adult mice. At early time points after administration of pI:pC (4-6 weeks), we observed a slight, but significant, increase in phenotypic HSCs (lineage-negative (Lin − ) Kit + Sca1 + CD150 + CD48 − ) in Huwe1-deficient bone marrow relative to that in control (Huwe1 +/Y Mx1-Cre + ) mice (P = 0.0041; Supplementary Fig. 1c ). However, at later time points of analysis (4-6 months after deletion), HSCs were severely reduced, in both frequency and absolute number, in the bone marrow of Huwe1 F/Y Mx1-Cre + mice ( Fig. 1a-c) , which suggesed that expansion and subsequent contraction of the self-renewing HSC population occurred following the loss of Huwe1.
To assess the consequences of Huwe1 loss on HSC function in vivo, we competitively transplanted bone marrow from Huwe1 F/Y Mx1-Cre + (hemizygous knockout) donors or Huwe1 +/Y Mx1-Cre + (control) donors with an equal number of wild-type bone marrow cells into lethally irradiated congenic recipients ( Fig. 1d) , then administered pI:pC to the recipients 3 weeks after this transplantation. The contribution from the Huwe1-deficient donors to peripheral blood chimerism decreased significantly over time and was almost completely undetectable 12 weeks after treatment with pI:pC ( Fig. 1d) . These data suggested that the stem-cell defect in Huwe1-deficient mice was cell intrinsic and could not be attributed to a failure to home to bone marrow, as we observed these effects with deletion after engraftment. Similarly, the in vitro colony-forming ability of isolated Huwe1-deficient hematopoietic stem and progenitor cells (HSPCs; Lin − Kit + Sca1 + ) was also impaired following serial passaging (Supplementary Fig. 1d ). Analysis of the bone marrow of transplant recipients revealed a substantial reduction in total donor-derived cells and a marked loss of donor-derived HSCs in the Huwe1-deficient cohort relative to their abundance in the control group ( Supplementary Fig. 1e,f) .
Given that the onset of hematopoietic defects in mice with conditional knockout of Huwe1 was more rapid after transplantation than in 'primary' mice, we further investigated how Huwe1-deficient HSCs responded to acute stress. Treatment with the chemotherapeutic agent 5-fluorouracil (5-FU) specifically ablates rapidly dividing hematopoietic progenitor cells and subsequently induces cycling of otherwise quiescent HSCs to replenish these progenitor pools 22 . Thus, we investigted how Huwe1-deficient mice responded to serial challenge with 5-FU. In this context, Huwe1-deficient mice exhibited much shorter survival than that of control mice ( Fig. 1e ). We hypothesized that this enhanced susceptibility to repetitive challenge with 5-FU was a result of an inability of Huwe1-deficient HSCs to reenter quiescence. Accordingly, ~70% of control HSCs were in resting phase (G0) 14 d after 5-FU treatment, whereas only about half (36%) of Huwe1deficient HSCs were in G0 at the same time point ( Supplementary  Fig. 1g ). We also observed that Huwe1-deficient HSCs were less quiescent than control HSCs under steady-state conditions ( Fig. 1f) , albeit to a lesser extent than after treatment with 5-FU.
To avoid any potential complications resulting from activation of interferon response in the Mx1-Cre model 23 , we also generated Fig. 2a,b ) but gave rise to fewer colonies in vitro than did their control counterparts ( Supplementary Fig. 2c ). Conversely, adult Huwe1 F/Y Vav1-Cre + mice had significantly fewer bone marrow HSCs than their wild-type littermates had, and the latency of this phenotype was notably shorter than that in the inducible Mx1-Cre model ( Fig. 2a ). Together these findings suggested that Huwe1 was essential for the quiescence and self-renewal of adult HSCs both at steady state and in stress conditions.
Huwe1 is essential for early lymphoid specification Notably, we observed substantially fewer early lymphoid progenitors and developing B cells in the bone marrow of Huwe1-deficient npg mice than in that of age-matched control mice ( Fig. 2a-c) . However, erythroid and myeloid populations were not correspondingly reduced ( Fig. 2d) , which suggested that the reduction in the abundance of lymphoid progenitors was not merely a consequence of diminishing HSC function. Commitment to the T cell lineage was also diminished in Huwe1-deficient mice, which resulted in thymi that were much smaller, with lower cellularity ( Fig. 2e and Supplementary Fig. 3a) . Thus, we concluded that Huwe1 also has a crucial role in early fate 'decisions' in HSCs, as demonstrated by the loss of the earliest lymphoid-biased or restricted progenitors (Flt3 + multipotent progenitors and common lymphoid progenitors) in the bone marrow 25 . This effect was cell intrinsic, as sorted Huwe1-deficient HSPCs were also defective or delayed in their ability to give rise to B cells and T cells in co-cultures with OP9 mouse bone marrow stromal cells ( Supplementary Fig. 3b,c) .
In contrast to the results reported above, approximately half of Huwe1 F/Y Vav1-Cre + mice that were older than 4 months exhibited signs of myelo-proliferation, accompanied by lower hemoglobin and red blood cell counts ( Supplementary Fig. 4a,b ) and slightly elevated white blood cell counts (Supplementary Fig. 4c ). The majority of nucleated cells in the peripheral blood were granulocytes or monocytes ( Supplementary Fig. 4d,e ). The spleens of these aged Huwe1-deficient mice also had a markedly disrupted architecture characterized by a loss of distinguishable boundary between the white pulp and red pulp and a twofold or greater population expansion of CD11b + cells relative to that of spleens from their age-matched control littermates (Supplementary Fig. 4f ). These observations indicated that loss of Huwe1 altered the differentiation balance, which led to substantial loss of lymphoid progenitors and, in a subset of mice, indicators of myelo-proliferative neoplasms.
Mapping N-myc and c-Myc in vivo
We hypothesized that the hematopoietic defects of Huwe1-deficient mice were a consequence of changes in the activity of Myc proteins.
Myc and Mycn are the two genes of the Myc-encoding family that are expressed predominantly in hematopoietic progenitors 7 . Given that the Myc G allele encoding a fusion of c-Myc and green fluorescent protein (GFP) has proven useful for assessing the post-transcriptional regulation of c-Myc in heterogeneous populations of cells 14, 26, 27 , we sought to generate a similar fusion allele for Mycn. We generated a targeting construct in which cDNA encoding the red fluorescent protein mCherry was cloned in frame with the first translated ATG in Mycn (Mycn M ) ( Supplementary Fig. 5a ). Immunoblot analysis of N-myc in normal and targeted embryonic stem cells (ESCs) confirmed that an immunoreactive protein product of approximately 95 kilodaltons (kDa) was expressed exclusively in the properly targeted ESCs (Fig. 3a) . Consequently, we observed a marked shift in mCherry fluorescence in ESCs that expressed the N-myc-mCherry fusion product (Fig. 3b) . We used two independent ESC clones to establish N-myc-mCherry (Mycn M ) mouse lines in which the fusion protein would be expressed in all tissues. Intercrossing of Mycn M/+ mice resulted in homozygous Mycn M/M pups at the expected Mendelian ratio, and these mice developed to adulthood without any discernable defects (data not shown).
Although we observed robust expression of N-myc-mCherry in ESCs, mCherry fluorescence was almost completely undetectable in the majority of hematopoietic cells from Mycn M/M adult mice (Fig. 3c) . In contrast to c-Myc-GFP, which is expressed at the highest levels in thymocytes at double-negative stages 3 and 4 (CD4 − CD8 − CD25 + CD44 − ) and Lin − Kit + Sca1 − bone marrow progenitors, N-myc-mCherry expression was restricted to the most primitive stem and progenitor compartments, such as HSCs and early thymic precursors (CD4 − CD8 − CD25 − CD44 hi Kit + ), and tapered off rapidly in more restricted progenitors ( Fig. 3c) . To assess whether the N-myc-mCherry fusion could be used to faithfully identify cells with differential abundance of N-myc protein, we sorted HSCs from the bone marrow of Mycn M/M mice on the basis A r t i c l e s of mCherry fluorescence (N-myc hi and N-myc lo ) and subjected them to microarray gene-expression profiling. Accordingly, genes upregulated in tumors in which N-myc was amplified were 'enriched' in expression in N-myc hi HSCs relative to their expression in N-myc lo HSCs (Supplementary Fig. 5b,c) . In contrast to results obtained for c-Myc hi HSPCs 14 , the N-myc hi HSCs showed enrichment for gene signatures associated with adult stem-cell populations (Supplementary Fig. 5d ).
Next we investigated whether HSCs with differential expression of c-Myc or N-myc protein were functionally distinct. For this, we sorted HSCs from the bone marrow of Mycn M/M Myc G/G mice into four populations (I-IV) on the basis of the intensity of the fluorescence of GFP and mCherry ( Fig. 3d) and transplanted the cells into lethally irradiated recipients. Recipients of c-Myc hi HSCs (III and IV) had a significantly lower frequency of donor-derived cells in their peripheral blood over time than that of recipients of c-Myc lo HSCs (I and II) ( Fig. 3e) . That finding agreed with the observation that HSPCs with higher expression of c-Myc have diminished self-renewal ability 14 . The abundance of N-myc, on the other hand, was not a clear determinant of stemness, as recipients of either c-Myc lo N-myc hi (II) HSCs or c-Myc lo N-myc lo (I) HSCs had equivalent levels of donor chimerism over time (Fig. 3e) . These data suggested that self-renewing HSCs 'preferentially' expressed N-myc and revealed that high c-Myc expression could serve as an early indicator of HSC differentiation.
Under stress conditions in which HSCs are stimulated to proliferate, c-Myc expression has been found to increase accordingly 28 . To determine whether the abundance of N-myc can respond dynamically to hematopoietic stress, we gave Mycn M/M Myc G/G mice injection of 5-FU or pI:pC and measured the fluorescence of mCherry or GFP in HSCs 4 d later. Given that HSCs downregulate their expression of the cell-surface marker c-kit in response to treatment with 5-FU, we used an alternative set of cell-surface markers to identify HSCs in 5-FUtreated bone marrow (Fig. 4a) . As with our analysis of c-Myc, we observed a significant accumulation of N-myc in HSCs from mice treated with either 5-FU or pI:pC (Fig. 4b,c ), which indicated that N-myc expression was also upregulated in HSCs as they proliferate in response to stress. This observation led us to hypothesize that depletion of N-myc might impair HSC proliferation in response to 5-FU. To our surprise, Mycn F/F Mx1-Cre + mice had twofold more HSCs than their control (Mycn F/+ Mx1-Cre + ) littermates had, after treatment with 5-FU ( Fig. 4d) . By comparison, loss of Huwe1 had the opposite effect, severely compromising recovery of the HSC pool after treatment with 5-FU ( Fig. 4d) .
Loss of Huwe1 stabilizes N-myc protein in HSCs
To reliably address the effect of Huwe1 depletion on the stability of N-myc, we first relied on the well-characterized HSPC-like mouse cell line HPC-7 (ref. 29) . Like HSCs, HPC-7 cells can undergo multi-lineage differentiation, depend on stem-cell factor (SCF) for their population expansion and express both N-myc and c-Myc (Fig. 5a) . HPC-7 cells were transduced with a retroviral short hairpin RNA (shRNA) construct targeting Huwe1 or the gene encoding renilla luciferase (as a negative control). Following knockdown of Huwe1, we observed significant accumulation of N-myc but not of c-Myc (Fig. 5a) . We assessed several other known substrates of Huwe1, including p53, Miz1 and Mcl1 (refs. 17, 30, 31) , but found no increase in these proteins (Fig. 5a) . Given that Huwe1 has also been linked to signaling via mitogen-activated protein kinases and Wnt 32,33 , we also measured phosphorylated Erk kinases and β-catenin but found that neither was affected by depletion of Huwe1 (Fig. 5a) . To address npg whether the accumulation of N-myc was proteasome dependent, we repeated the Huwe1-knockdown study in the presence of the proteasome inhibitor MG-132. The addition of MG-132 significantly stabilized N-myc in cells expressing the control shRNA, whereas this effect was greatly diminished in cells in which Huwe1 was depleted ( Fig. 5b) . However, p53 was still strongly stabilized in both conditions 34 (Fig. 5b) . Given that proteins that are polyubiquitinated via lysine 48 (K48) linkage are spared from degradation following proteasome inhibition, this indicated that there was less ubiquitinated N-myc after knockdown of Huwe1. Next, to investigate whether loss of Huwe1 also resulted in the accumulation of N-myc in primary HSCs, we crossed mice with conditional knockout of Huwe1 with the N-myc-mCherry and c-Myc-GFP fusion line to generate Huwe1 F/Y Mx1-Cre + Mycn M/M Myc G/G mice. We found that at 3 weeks after treatment with pI:pC, Huwe1-deficient HSCs expressed approximately threefold more N-myc protein than did wild-type HSCs, as determined by mCherry fluorescence (Fig. 5c,d) .
We observed a similar increase in N-myc in Huwe1-deficient common myeloid progenitors but not in more lineage-restricted progenitors, such as granulocyte-macrophage progenitors (Fig. 5c) .
In contrast, c-Myc abundance was unchanged in Huwe1-deficient HSCs or myeloid progenitors (Fig. 5c) . Given this and our observations of HPC-7 cells, we concluded that Huwe1 targets N-myc for proteasomal degradation in HSCs.
Disruption of HSC transcriptional identity by Huwe1 loss
Given that transcription factors of the Myc family have been shown to bind to and influence transcription of a wide distribution of targets, we hypothesized that the stabilization of N-myc that occurred in Huwe1deficient HSCs would have profound consequences on gene expression. Thus, we performed high-throughput RNA sequencing of HSCs sorted from wild-type, Huwe1 F/Y Mx1-Cre + and Huwe1 F/Y Vav1-Cre + mice and analyzed transcripts that were expressed differentially (Fig. 6a ). We found that 53 genes were significantly upregulated and 224 genes were significantly downregulated in Huwe1-deficient HSCs relative to their expression in wild-type HSCs ( Supplementary  Fig. 6a ). The upregulated transcripts included targets of the transcription factor E2F and genes encoding products involved in cellcycle progression (Fig. 6b) , consistent with our observation that Huwe1-deficient HSCs were more proliferative. The expression of Stat1 mRNA and interferon-responsive genes was also elevated in Huwe1-deficient HSCs relative to their expression in wild-type HSCs (Fig. 6c) . Conversely, one of the gene sets that was most significantly downregulated in Huwe1-deficient HSCs relative to their expression in wild-type HSCs included genes 'enriched' in long-term self-renewing HSCs 35 (Fig. 6b) . These downregulated genes included those encoding many critical mediators of HSC quiescence, such as Mpl, Tek (Tie-2), Cdkn1c (p57), Runx1t1 (Eto) and Ndn (Necdin) [36] [37] [38] (Fig. 6c) . Genes encoding many key effectors of early lymphoid specification, such as Notch1, , were also significantly downregulated in Huwe1-deficient HSCs relative to their expression in wild-type HSCs (Fig. 6c) .
To address whether those changes in gene expression were a result of an increase in N-myc, we ectopically expressed N-myc in wild-type HSCs and measured several of the differentially expressed transcripts by quantitative real-time PCR (qRT-PCR). In accordance with the results reported above, the expression of Mpl, Ndn, Satb1 and Tek was decreased and Stat1 expression was increased in HSCs following enforced expression of N-myc (Fig. 6d) . To determine which of those genes are direct targets of N-myc, we performed chromatin immunoprecipitation followed by deep sequencing (ChIP-seq) to identify regions bound by N-myc in mobilized human CD34 + stem and progenitor cells. Across replicates, we identified 4,466 genomic peaks with significant enrichment for N-myc (data not shown). The largest proportion of peaks were in gene promoter regions ( Supplementary  Fig. 6b ) and correlated with enrichment for active histone marks, such as H3K27 acetylation and H3K4 trimethylation ( Supplementary  Fig. 6c ), a pattern that has been observed for loci bound by c-Myc. Notably, many of the genes that were found to be expressed differentially in the Huwe1-deficient HSCs relative to their expression in wild-type HSCs, such as STAT1, CDK6 and SATB1, were bound by N-myc ( Fig. 6e) . Thus, we concluded that the transcriptional changes that we observed following the loss of Huwe1 were a result, at least in part, of stabilization of N-myc.
Depletion of N-myc in Huwe1-deficient mice restores HSC pool
To determine whether the phenotypes of Huwe1-deficient HSCs were dependent on the accumulation of N-myc, we crossed Huwe1 F/Y Mx1-Cre mice to a line with conditional knockout of Mycn (Mycn F/F ) to generate mice with double knockout of Huwe1 and Mycn (dKO mice). Unlike Huwe1-deficient mice, aged dKO mice retained a normal population of HSCs in their bone marrow (Fig. 7a,b) . Depletion of Mycn in Huwe1deficient mice also restored HSC quiescence ( Fig. 7c) and serial colonyforming ability (Supplementary Fig. 7a) . Accordingly, the expression of Cdkn1c, Cdk6 and Stat1 was restored to normal levels in dKO HSCs (Fig. 7d) . Deletion of a single allele of Mycn led to a slight but nonsignificant increase in phenotypic HSCs in the bone marrow of Huwe1deficient mice (P = 0.2634; Supplementary Fig. 7b ). However, early lymphoid progenitor populations were only minimally 'rescued' in dKO mice (Fig. 7e) , which suggested that the loss of lymphoid priming in Huwe1-deficient HSCs was largely N-myc independent. Following transplantation, dKO donor bone marrow provided long-term myeloid reconstitution in recipient mice comparable to that provided by wild-type donor bone marrow (Fig. 7f ), yet lymphoid reconstitution by both the dKO donor bone marrow and Huwe1-deficient donor bone marrow decreased over time (data not shown). Unexpectedly, aged mice deficient in Mycn alone had nearly twofold more HSCs than their aged control littermates had (Fig. 7b) . We did not attribute Fig. 7c,d) . To assess whether other known substrates might also account for hematopoietic defects observed in Huwe1-deficient mice, we simultaneously infected Huwe1 F/Y HSPCs with retroviruses encoding Cre and various shRNAs and assessed the ability of the doubly transduced cells to form colonies in vitro. We tested shRNAs targeting a panel of previously identified Huwe1 substrates, including the genes encoding topoisomerase II binding protein 1 (Topbp1), Rev-ErbA-α (Nr1d1) and p53 (Trp53), as well as Mycn 42, 43 , in this assay, as well as the control shRNA noted above. Of all the constructs tested, only shRNA targeting Mycn was able to restore the serial colony-forming ability of HSPCs depleted of Huwe1 (Supplementary Fig. 7e ). Collectively these data suggested that Huwe1 regulates HSC self-renewal by maintaining homeostatic amounts of N-myc as HSCs exit and reenter quiescence.
DISCUSSION
Our findings have demonstrated a previously unknown role for the E3 ligase Huwe1 in the maintenance of HSC homeostasis, which adds another example of how the ubiquitination and relative abundance of Myc proteins can have a critical role in developmental processes.
The observation that Huwe1 was able to regulate the stability of N-myc but not that of c-Myc was notable, given the unspecified function of N-myc in HSCs. Unlike what has been observed for conditional knockout of Myc, loss of Mycn does not appear to impair adult HSC differentiation 7 , but instead led to the accumulation of HSCs in aged mice. However, whether N-myc has a unique role in fetal or stress hematopoiesis remains an open question; substantial enrichment in N-myc expression has been observed in these conditions 44 .
In addition, we observed a contrast in the abundance of N-myc and c-Myc in HSCs and multipotent progenitors. Whereas others have reported that Myc and Mycn transcripts are coexpressed in the most immature populations of HSCs, this was quantified in a heterogeneous population of cells 7 . Using our fluorescent fusions of c-Myc and N-myc, we were able to quantify the abundance of both proteins at the single-cell level for the first time, to our knowledge. Instead of finding uniform co-expression of both proteins in HSCs, we observed many cells in which expression of N-myc and that of c-Myc was mutually exclusive. Whether these cells are functionally unique or not remains an intriguing possibility. Clearly, given our gene-expression analysis of N-myc hi and N-myc lo HSCs, there were some distinct molecular differences between these populations, but we found that these populations performed similarly in transplantation assays. Still, the 
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A r t i c l e s evident switch from N-myc expression in self-renewing, quiescent stem cells to higher c-Myc expression in transit-amplifying progenitors has implications for unique functions of members of the Myc family at the molecular level. Overexpression of Mycn has been shown to enhance the reprogramming of mature blood cells to induced HSCs 45 , which suggests that N-myc, in particular, helps to activate a stem-like identity in hematopoietic cells. Although there are many similarities in the hematopoietic phenotypes of mice with conditional deficiency in Huwe1 and those with conditional deficiency in Fbxw7, there are some notable differences in these that might shed light on the role of these ubiquitin ligases in HSCs. From our observations of mice with conditional deficiency in Huwe1, we propose that this gradual decrease in the HSC pool indicated a failure to reenter quiescence, rather than compulsory cellcycle entry and differentiation, for which we would expect a more pronounced phenotype. Thus, in stress scenarios, such as transplantation or myeloablation, HSC exhaustion in Huwe1-deficient mice was much more apparent. At steady state, the onset of HSC depletion was considerably slower in Huwe1-deficient mice than in Fbxw7-deficient mice, and depletion of Huwe1 in adult mice did not lead to fatal anemia. There are several potential mechanistic explanations as to why this could be the case. For one such explanation, we observed that both c-Myc and N-myc accumulated in Fbxw7-deficient HSCs (data not shown), whereas only N-myc appeared to be stabilized following loss of Huwe1. Thus, the net sum of Myc proteins would be higher in Fbxw7-deficient HSCs and this could result in further amplification in the expression of genes that are targets of c-Myc and N-myc 46 . Alternatively, it is possible that N-myc might be a weaker transcriptional activator than c-Myc. This was hypothesized decades ago 47 , but was challenged by the fact that mice with homozygous knock-in of Mycn into the Myc locus develop normally 48 . However, to the best of our knowledge, the effect of equivalently overexpressing either c-Myc or N-myc in HSCs has not been directly compared thus far. Published studies have also shown that K63 ubiquitination of c-Myc by Huwe1 can affect its affinity for transcriptional coactivators or Miz-1, a component of a ternary complex with Max ('Myc-associated factor X') that is found at loci that are repressed by c-Myc 18 . If Huwe1 also regulates N-myc in a similar manner, loss of Huwe1 would not only lead to stabilization of N-myc but also alter its activity. In support of that hypothesis, we observed that more genes were downregulated than upregulated in HSCs following loss of Huwe1, contrary to what we observed for Fbxw7-deficient HSCs.
Finally, if Huwe1 and Fbxw7 are both ubiquitinating the same substrate, does this mean that there is a convergence of these two E3 complexes in the same pathway? It is possible that N-myc could be ubiquitinated sequentially or in a concerted fashion by the two E3 complexes. Successive elongation of polyubiquitin chains on protein substrates by multiple ubiquitin ligase complexes has been observed in yeast 49 . It is also possible that the two ligases would act downstream of different signals. Substrate recognition by Fbxw7 depends heavily on the activity of priming kinases (for example, Gsk3β), whereas the events that lead to substrate ubiquitination by Huwe1 are still poorly defined. Future studies should investigate whether Huwe1 is still able to ubiquitinate N-myc with missense substitutions in its phosphodegron or following inhibition of Gsk3β, both of which would block the binding of N-myc to Fbxw7. In addition to Huwe1 and Fbxw7, there are several other E3 ligases that have been shown to regulate ubiquitination of Myc proteins 50 , and it is only through these sort of genetic and biochemical studies that the complex interplay of these proteins in HSCs will be elucidated.
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